<h4>Background</h4>While amyloid-β (Aβ) and tau are hallmark pathologies of Alzheimer's disease (AD), TDP-43 proteinopathy is increasingly recognized as an important contributor, occurring in up to 57% of AD cases and associated with accelerated cognitive decline. The gene discussed is TARDBP; the disease is proteostasis deficiencies.